Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantDKSH SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Medical Information
N06DX05
Manufacturer Information
DKSH SINGAPORE PTE. LTD.
Lilly France
Active Ingredients
Documents
Package Inserts
LORMALZI PI.pdf
Approved: March 11, 2025